SCHEMBL18441111

SCHEMBL18441111

CC=Cc1ccccc1OC(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
PTGES2 Q9H7Z7 1/20 0.45
POLB P06746 2/20 0.43
CA12 O43570 3/20 0.43
CA9 Q16790 3/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
NFE2L2 Q16236 2/20 0.42
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GAA P10253 1/20 0.41
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
DRD1 P21728 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TRPA1 O75762 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1073157 0.82 AR (0.46) L3MBTL1PTGES2NFE2L2MAPTSMN1; SMN2
SCHEMBL1073158 0.82 AR (0.46) L3MBTL1PTGES2NFE2L2MAPTSMN1; SMN2
SCHEMBL3717231 0.82 AR (0.46) L3MBTL1PTGES2NFE2L2MAPTSMN1; SMN2
SCHEMBL3669785 0.77 NFE2L2 (0.45) NFE2L2MAPTSMN1; SMN2GAALMNA
SCHEMBL21110871 0.77 NFE2L2 (0.45) NFE2L2MAPTSMN1; SMN2GAALMNA
SCHEMBL5426283 0.77 PTGES2 (0.42) L3MBTL1PTGES2POLBCA12CA9
SCHEMBL5426281 0.77 PTGES2 (0.42) L3MBTL1PTGES2POLBCA12CA9
SCHEMBL18145871 0.77 PTGES2 (0.42) L3MBTL1PTGES2POLBCA12CA9
SCHEMBL18145870 0.77 PTGES2 (0.42) L3MBTL1PTGES2POLBCA12CA9
SCHEMBL15678969 0.76 POLB (0.45) L3MBTL1PTGES2POLBCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331889-A1 CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA Bristol-Myers Squibb Company (US) 2018-06-13 EP disclosed
WO-2017023902-A1 CYCLIC COMPOUNDS USEFUL AS MODULATORS OF TNF ALPHA BRISTOL-MYERS SQUIBB COMPANY (US) 2017-02-09 WO disclosed